Matrix metalloproteinases: therapeutic targets for glucose induced cardiotoxicity — ASN Events
  1. Schedule
  2. ADS Basic Poster Session
  3. Matrix metalloproteinases: therapeutic targets for glucose induced cardiotoxicity

Matrix metalloproteinases: therapeutic targets for glucose induced cardiotoxicity (#216)

Daniel Hesselson 1
  1. Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
Publish consent withheld
  1. Camp, T.M., S.C. Tyagi, R.M. Senior, M.R. Hayden, and S.C. Tyagi. 2003. Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice. Diabetologia. 46:1438-1445.
  2. Marx, N., J. Froehlich, L. Siam, J. Ittner, G. Wierse, A. Schmidt, H. Scharnagl, V. Hombach, and W. Koenig. 2003. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arteriosclerosis, thrombosis, and vascular biology. 23:283-288.